Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
This study has been completed.
Study NCT00268697   Information provided by Takeda Global Research & Development Center, Inc.

First Received on December 20, 2005.   Last Updated on May 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
Additional conditions recognized in this trial
Dyslipidemias
More general conditions related to this trial
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Lapaquistat acetate
Lapaquistat acetate and ezetimibe
Ezetimibe
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research & Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services